Long-Term Safety and Tolerability of a New Formulation of Epoprostenol in Pulmonary Arterial Hypertension (PAH) Patients: Final Results from EPITOME-2

Authors
Category Primary study
JournalJournal of Heart and Lung Transplantation
Year 2016
This article has no abstract
Epistemonikos ID: 29682e6e107802986c4cbfc7b7d6559b5ae14539
First added on: Feb 12, 2025